In present study, given that the expression of ST8SIA4 was down-regulated by miR-181c in CML cells (Figure 4), we further investigated whether dysregulation miR-181c altered the activation of PI3K/AKT pathway. This evidence concerns the gene ST8SIA4 and chronic myelogenous leukemia, BCR-ABL1 positive.